# Genetic Variants in Egyptian Patients Receiving HCQ(Hydroxychloroquine)

> **NCT03180190** · — · UNKNOWN · sponsor: **Assiut University** · enrollment: 50 (estimated)

## Conditions studied

- Autoimmune Diseases

## Interventions

- **DRUG:** Hydroxychloroquine Oral Tablet

## Key facts

- **NCT ID:** NCT03180190
- **Lead sponsor:** Assiut University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2017-06-28
- **Primary completion:** 2018-06-28
- **Final completion:** 2018-07-28
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2017-06-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03180190

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03180190, "Genetic Variants in Egyptian Patients Receiving HCQ(Hydroxychloroquine)". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03180190. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*